Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion type Assertion NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_head.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion description "[If chemically stable FAS inhibitors or cell-selective vector systems able to deliver RNAi targeting FAS gene demonstrate systemic anticancer effects in vivo, our results render FAS as a novel target for the prevention and treatment of endometrial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_provenance.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion evidence source_evidence_literature NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_provenance.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion SIO_000772 15094777 NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_provenance.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion wasDerivedFrom befree-20150227 NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_provenance.
- NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_assertion wasGeneratedBy ECO_0000203 NP1014175.RAUaPci5Ja1W7zvOlyICHkRw-hoJHRevJyuJWbFtS6_00130_provenance.